Work

Results of a Phase I Study of Vorinostat In Combination with Pegylated Liposomal Doxorubicin and Bortezomib In Patients with Relapsed/Refractory Multiple Myeloma

Year: 2010

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v116.21.1955.1955

Authors: Peter M Voorhees, Cristina Gasparetto, Keren Osman, Kristy Richards, Madlyn Ferraro, Reynaldo Garcia, Jennifer MacLean, Diane Winans, Dominic Moore, John Strader, Robert Z. Orlowski, David Duane Hurd

Institutions: University of North Carolina at Chapel Hill, Duke Medical Center, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, Wake Forest University Health Sciences, Wake Forest University, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2550544585

FWCI: 1.198

Cites:

Cited by: 9

Related to: 10